15-65077358-C-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_001101362.3(KBTBD13):c.543C>G(p.Asp181Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000667 in 1,500,140 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D181Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_001101362.3 missense
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 6Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152130Hom.:  0  Cov.: 33 show subpopulations 
GnomAD4 exome  AF:  0.00000519  AC: 7AN: 1348010Hom.:  0  Cov.: 40 AF XY:  0.00000757  AC XY: 5AN XY: 660264 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000197  AC: 3AN: 152130Hom.:  0  Cov.: 33 AF XY:  0.00  AC XY: 0AN XY: 74318 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Nemaline myopathy 6    Uncertain:2 
- -
This sequence change replaces aspartic acid with glutamic acid at codon 181 of the KBTBD13 protein (p.Asp181Glu). The aspartic acid residue is moderately conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has not been reported in the literature in individuals with KBTBD13-related conditions. ClinVar contains an entry for this variant (Variation ID: 579317). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases    Uncertain:1 
The c.543C>G (p.D181E) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a C to G substitution at nucleotide position 543, causing the aspartic acid (D) at amino acid position 181 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at